163 related articles for article (PubMed ID: 18453750)
21. MiRNA-3978 regulates peritoneal gastric cancer metastasis by targeting legumain.
Zhang Y; Wu YY; Jiang JN; Liu XS; Ji FJ; Fang XD
Oncotarget; 2016 Dec; 7(50):83223-83230. PubMed ID: 27793040
[TBL] [Abstract][Full Text] [Related]
22. Genetic alterations and their clinical implications in gastric cancer peritoneal carcinomatosis revealed by whole-exome sequencing of malignant ascites.
Lim B; Kim C; Kim JH; Kwon WS; Lee WS; Kim JM; Park JY; Kim HS; Park KH; Kim TS; Park JL; Chung HC; Rha SY; Kim SY
Oncotarget; 2016 Feb; 7(7):8055-66. PubMed ID: 26811494
[TBL] [Abstract][Full Text] [Related]
23. shRNA-mediated inhibition of PhosphoGlycerate Kinase 1 (PGK1) enhances cytotoxicity of intraperitoneal chemotherapy in peritoneal metastasis of gastric origin.
Archid R; Zieker D; Weinreich FJ; Hönes F; Königsrainer A; Quintanilla-Martínez L; Reymond MA; Solass W
Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):613-619. PubMed ID: 31980221
[TBL] [Abstract][Full Text] [Related]
24. Detection of minimal gastric cancer cells in peritoneal washings by focused microarray analysis with multiple markers: clinical implications.
Mori K; Suzuki T; Uozaki H; Nakanishi H; Ueda T; Matsuno Y; Kodera Y; Sakamoto H; Yamamoto N; Sasako M; Kaminishi M; Sasaki H
Ann Surg Oncol; 2007 May; 14(5):1694-702. PubMed ID: 17294072
[TBL] [Abstract][Full Text] [Related]
25. Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers.
Sakakura C; Hasegawa K; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Yazumi S; Yamagishi H; Okanoue T; Chiba T; Hagiwara A
Clin Cancer Res; 2005 Sep; 11(18):6479-88. PubMed ID: 16166423
[TBL] [Abstract][Full Text] [Related]
26. TIP60 as a potential marker for the malignancy of gastric cancer.
Sakuraba K; Yokomizo K; Shirahata A; Goto T; Saito M; Ishibashi K; Kigawa G; Nemoto H; Hibi K
Anticancer Res; 2011 Jan; 31(1):77-9. PubMed ID: 21273583
[TBL] [Abstract][Full Text] [Related]
27. Integrated Molecular Profiling of Human Gastric Cancer Identifies DDR2 as a Potential Regulator of Peritoneal Dissemination.
Kurashige J; Hasegawa T; Niida A; Sugimachi K; Deng N; Mima K; Uchi R; Sawada G; Takahashi Y; Eguchi H; Inomata M; Kitano S; Fukagawa T; Sasako M; Sasaki H; Sasaki S; Mori M; Yanagihara K; Baba H; Miyano S; Tan P; Mimori K
Sci Rep; 2016 Mar; 6():22371. PubMed ID: 26934957
[TBL] [Abstract][Full Text] [Related]
28. Mechanistic role of p38 MAPK in gastric cancer dissemination in a rodent model peritoneal metastasis.
Graziosi L; Mencarelli A; Santorelli C; Renga B; Cipriani S; Cavazzoni E; Palladino G; Laufer S; Burnet M; Donini A; Fiorucci S
Eur J Pharmacol; 2012 Jan; 674(2-3):143-52. PubMed ID: 22119383
[TBL] [Abstract][Full Text] [Related]
29. [Expression of galectin-3 mRNA in gastric cancer with peritoneal metastasis].
Yang ZM; Wu XT; He T; Da MX; Luo T; Qian K
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):105-8. PubMed ID: 16468655
[TBL] [Abstract][Full Text] [Related]
30. Phosphoglycerate kinase-1 is a predictor of poor survival and a novel prognostic biomarker of chemoresistance to paclitaxel treatment in breast cancer.
Sun S; Liang X; Zhang X; Liu T; Shi Q; Song Y; Jiang Y; Wu H; Jiang Y; Lu X; Pang D
Br J Cancer; 2015 Apr; 112(8):1332-9. PubMed ID: 25867275
[TBL] [Abstract][Full Text] [Related]
31. Epigenetic modulation and repression of miR-200b by cancer-associated fibroblasts contribute to cancer invasion and peritoneal dissemination in gastric cancer.
Kurashige J; Mima K; Sawada G; Takahashi Y; Eguchi H; Sugimachi K; Mori M; Yanagihara K; Yashiro M; Hirakawa K; Baba H; Mimori K
Carcinogenesis; 2015 Jan; 36(1):133-41. PubMed ID: 25411357
[TBL] [Abstract][Full Text] [Related]
32. Gene expression changes induced by HIPEC in a murine model of gastric cancer.
Graziosi L; Mencarelli A; Renga B; Santorelli C; Cantarella F; Bugiantella W; Cavazzoni E; Donini A; Fiorucci S
In Vivo; 2012; 26(1):39-45. PubMed ID: 22210714
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of RegIV in peritoneal dissemination of gastric cancer and its potential as A novel marker for the detection of peritoneal micrometastasis.
Miyagawa K; Sakakura C; Nakashima S; Yoshikawa T; Fukuda K; Kin S; Nakase Y; Shimomura K; Oue N; Yasui W; Hayasizaki H; Okazaki Y; Yamagishi H; Hagiwara A; Otsuji E
Anticancer Res; 2008; 28(2B):1169-79. PubMed ID: 18505053
[TBL] [Abstract][Full Text] [Related]
34. Expression of MMP-7 and MT1-MMP in peritoneal dissemination of gastric cancer.
Yoshikawa T; Yanoma S; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Miyagi Y; Morinaga S; Noguchi Y; Yamamoto Y
Hepatogastroenterology; 2006; 53(72):964-7. PubMed ID: 17153464
[TBL] [Abstract][Full Text] [Related]
35. Prognostic relevance of Tensin4 expression in human gastric cancer.
Sakashita K; Mimori K; Tanaka F; Kamohara Y; Inoue H; Sawada T; Hirakawa K; Mori M
Ann Surg Oncol; 2008 Sep; 15(9):2606-13. PubMed ID: 18612693
[TBL] [Abstract][Full Text] [Related]
36. Bone marrow and peripheral blood expression of ID1 in human gastric carcinoma patients is a bona fide indicator of lymph node and peritoneal metastasis.
Iwatsuki M; Fukagawa T; Mimori K; Nakanishi H; Ito S; Ishii H; Yokobori T; Sasako M; Baba H; Mori M
Br J Cancer; 2009 Jun; 100(12):1937-42. PubMed ID: 19491902
[TBL] [Abstract][Full Text] [Related]
37. Examination of cancer cells exposed to gastric serosa by serosal stamp cytology plus RT-PCR is useful for the identification of gastric cancer patients at high risk of peritoneal recurrence.
Miki Y; Yashiro M; Ando K; Okuno T; Kitayama K; Masuda G; Tamura T; Sakurai K; Toyokawa T; Kubo N; Tanaka H; Muguruma K; Osawa M; Hirakawa K; Ohira M
Surg Oncol; 2017 Dec; 26(4):352-358. PubMed ID: 29113652
[TBL] [Abstract][Full Text] [Related]
38. Clinical significance of tartrate-resistant acid phosphatase type-5 expression in human gastric cancer.
Kawamura M; Tanaka K; Toiyama Y; Okugawa Y; Okigami M; Yasuda H; Saigusa S; Ohi M; Inoue Y; Uchida K; Mohri Y; Kusunoki M
Anticancer Res; 2014 Jul; 34(7):3425-9. PubMed ID: 24982350
[TBL] [Abstract][Full Text] [Related]
39. MACC 1 as a marker for peritoneal-disseminated gastric carcinoma.
Shirahata A; Sakata M; Kitamura Y; Sakuraba K; Yokomizo K; Goto T; Mizukami H; Saito M; Ishibashi K; Kigawa G; Nemoto H; Hibi K
Anticancer Res; 2010 Sep; 30(9):3441-4. PubMed ID: 20944120
[TBL] [Abstract][Full Text] [Related]
40. PLOD2 as a potential regulator of peritoneal dissemination in gastric cancer.
Kiyozumi Y; Iwatsuki M; Kurashige J; Ogata Y; Yamashita K; Koga Y; Toihata T; Hiyoshi Y; Ishimoto T; Baba Y; Miyamoto Y; Yoshida N; Yanagihara K; Mimori K; Baba H
Int J Cancer; 2018 Sep; 143(5):1202-1211. PubMed ID: 29603227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
